Share this post on:

Product Name :
Ozagrel hydrochloride hydrate

Search keywords :
Ozagrel (hydrochloride)

drugId :
null

Target Vo:
Thromboxane A2 synthase

Target Vo Short Name :
TBXAS1

Moa_Name:
Thromboxane A2 synthase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1992

Origin Company_Name :
Ono Pharmaceutical Co Ltd

Active Company_Name :
Liaoning Sibaide Medicine Technology Co Ltd

Active Indication_Name:
Asthma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ferritin Heavy Chain Antibody
mTOR Antibody
Chk1 Antibody: Chk1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related